Marshall Wace North America’s Kellanova K Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-81,508
Closed -$4.84M 1615
2021
Q1
$4.84M Buy
+81,508
New +$4.56M 0.02% 575
2020
Q3
Sell
-43,160
Closed -$2.68M 1342
2020
Q2
$2.68M Sell
43,160
-45,121
-51% -$2.73M 0.02% 508
2020
Q1
$4.97M Buy
88,281
+66,217
+300% +$4.06M 0.04% 319
2019
Q4
$1.43M Sell
22,064
-48,735
-69% -$2.95M 0.01% 647
2019
Q3
$4.28M Sell
70,799
-34,177
-33% -$1.95M 0.02% 389
2019
Q2
$5.28M Buy
104,976
+99,970
+1,997% +$5.31M 0.03% 347
2019
Q1
$270K Buy
+5,006
New +$267K ﹤0.01% 919
2018
Q1
Sell
-160,350
Closed -$10.2M 1561
2017
Q4
$10.2M Buy
+160,350
New +$9.65M 0.06% 377

Other funds holding K

Marshall Wace North America's K Position: Q2 2021 in Review

Marshall Wace North America sold out of Kellanova (K) in Q2 2021, closing a stake of 81,508 shares — an estimated $4.84M sold.

Marshall Wace North America first reported a position in K in Q4 2017 and held it in 8 quarters. The position peaked at $10.2M in Q4 2017. 814 funds tracked by Wall St. Rank hold K as of Q2 2021.

  • Marshall Wace North America reported no remaining Kellanova position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 81,508 Kellanova shares in Q2 2021, an estimated $4.84M.
  • Marshall Wace North America first reported a position in Kellanova in Q4 2017 and held it in 8 quarters.
  • Marshall Wace North America's Kellanova position peaked at $10.2M in Q4 2017.
  • 814 funds tracked by Wall St. Rank held Kellanova as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.